Lincoln National Corp Boston Scientific Corp Transaction History

Lincoln National Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$57.6 - $68.62 $200,275 - $238,591	3,477 New	3,477 $238,000
Q2 2022 Aug 02, 2022	SELL	$35.24 - $47.1 $430,068 - $574,808	-12,204 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$40.9 - $45.1 $117,832 - $129,933	2,881 Added 30.9%	12,204 $541,000
Q4 2021 Jan 26, 2022	BUY	$38.07 - $44.87 $5,482 - $6,461	144 Added 1.57%	9,323 $396,000
Q3 2021 Nov 05, 2021	BUY	$41.23 - $45.88 $15,172 - $16,883	368 Added 4.18%	9,179 $398,000
Q1 2021 May 10, 2021	SELL	$35.27 - $39.67 $881 - $991	-25 Reduced 0.28%	8,811 $341,000
Q4 2020 Feb 05, 2021	BUY	$33.15 - $41.97 $292,913 - $370,846	8,836 New	8,836 $318,000

1,669

1.22B

8.76M

9.42M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $142B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.